Indrayani Biotech Limited (BOM:526445)
12.29
+0.16 (1.32%)
At close: Sep 12, 2025
Indrayani Biotech Revenue
Indrayani Biotech had revenue of 295.54M INR in the quarter ending June 30, 2025, a decrease of -33.41%. This brings the company's revenue in the last twelve months to 1.28B, down -22.84% year-over-year. In the fiscal year ending March 31, 2025, Indrayani Biotech had annual revenue of 1.30B, down -21.66%.
Revenue (ttm)
1.28B
Revenue Growth
-22.84%
P/S Ratio
0.42
Revenue / Employee
1.37M
Employees
1,112
Market Cap
544.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.30B | -359.97M | -21.66% |
Mar 31, 2024 | 1.66B | 32.96M | 2.02% |
Mar 31, 2023 | 1.63B | 1.01B | 164.57% |
Mar 31, 2022 | 615.82M | 403.91M | 190.60% |
Mar 31, 2021 | 211.91M | -287.06M | -57.53% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,839.41B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,503.84B |
Infosys | 1,672.76B |
Bajaj Finance | 387.76B |